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Tiivistelmä 
 
Tutkimuksen tausta ja tavoitteet: Miljoonia ihmisiä kuolee joka vuosi suolistoloisten 
aiheuttamiin sairauksiin. Kaksi epidemiologisesti tärkeää loista, Giardia lamblia ja 
Cryptosporidium, aiheuttavat esimerkiksi ripulia, oksentelua ja pahimmillaan imeytymishäiriöitä. 
Näiden loisten toteaminen on tähän asti tehty pääasiassa mikroskopoimalla, mutta kvantitatiivinen 
polymeraasiketjureaktio (qPCR) voisi olla menetelmänä tarkempi, herkempi sekä nopeampi. 
Menetelmällä voitaisiin myös tutkia useampia näytteitä yhtä aikaa. Tämän tutkimuksen tavoitteena 
oli optimoida menetelmät ja kehittää protokolla, jonka avulla voidaan todeta suolistoloiset Giardia 
lamblia ja Cryptosporidium (C. parvum ja C. hominis) kliinisistä ulostenäytteistä. Tavoitteena oli 
tehokas menetelmä, jota voidaan käyttää useiden näytteiden ja loisten yhtäaikaiseen tutkimiseen. 
Tutkimusmenetelmät: Giardia lamblia- tai Cryptosporidium hominis -positiivisia ihmisen 
ulostenäytteitä käytettiin erilaisten esikäsittelyiden (konsentrointimenetelmät, lämpökäsittelyt, 
sulatus-jäädytyssyklit ja proteinaasikäsittelyt) sekä niiden yhdistelmien tutkimiseen, jotta 
löydettäisiin optimaalinen menetelmä mahdollisimman suuren DNA-määrän vapauttamiseksi 
loisten (oo)kystista. Kaikkiaan kokeiltiin 13 erilaista protokollaa herkimmän menetelmän 
löytämiseksi. Menetelmän kehittämiseen sisältyi myös kolmen kaupallisen DNA-
eristysmenetelmän testaus sekä qPCR-reaktion aluke- ja koetinpitoisuuksien optimointi, jotka 
tehtiin ensin molemmille loisille erikseen, minkä jälkeen ne yhdistettiin samaan reaktioon. 
Menetelmän kehittämisen jälkeen DiabImmune-tutkimuksen näytteistä testattiin näitä loisia ja 
qPCR-reaktion toimivuus varmistettiin kliinisellä Cryptosporidium parvum –positiivisella 
näytteellä. 
Tutkimustulokset: Esikäsittely, joka koostui 10 minuutin lämpökäsittelystä (+98 °C) ja yön yli 
kestävästä proteinaasikäsittelystä (+56 °C), todettiin parhaaksi. Valinta tehtiin pääasiassa Giardia 
lamblia -näytteen tulosten perusteella, koska Cryptosporidium hominis –näyte monistui PCR-
menetelmällä vain heikosti ja näin ollen tulokset eivät olleet luotettavasti toistettavia. Virus-RNA:n 
eristämiseen tarkoitettu eristysmenetelmä osoittautui herkimmäksi. Erot eri qPCR-aluke- ja  
-koetinpitoisuuksien monistustehokkuuksien välillä olivat pieniä ja optimaalisiksi pitoisuuksiksi 
valittiin pienimmät konsentraatiot, jotka monistivat yhtä tehokkaasti kohdetemplaattia. 
Cryptosporidium-qPCR:n todettiin havaitsevan sekä C. hominista että C. parvumia. Kaikki 
DiabImmune-tutkimuksessa otetut taustaväestöä edustavien lasten ulostenäytteet olivat negatiivisia. 
Johtopäätökset: Tässä tutkimuksessa kehitetty protokolla on toistettava, herkkä ja useiden 
näytteiden yhtäaikaisen tutkimisen mahdollistava menetelmä, jolla voidaan todeta kyseisiä loisia 
ihmisten ulostenäytteistä. Koska Cryptosporidium hominis –näyte oli heikosti positiivinen, PCR-
menetelmän toimivuus varmistettiin C. parvum-positiivisella näytteellä. Tässä tutkimuksessa 
optimoitu Giardia lamblian ja Cryptosporidiumin osoitukseen kehitetty protokolla on otettu 
käyttöön professori Heikki Hyödyn laboratoriossa. 
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Abstract 
 
Background and aims: Millions of people die every year of intestinal parasite diseases. Two 
epidemiologically important parasites, Giardia lamblia and Cryptosporidium species (spp.) cause 
e.g. diarrhoea, vomiting and at worst malabsorption. Detection of these parasites has thus far been 
done by e.g. microscopy, but quantitative polymerase chain reaction (qPCR) would be a more 
accurate, sensitive and less time-consuming method and more samples could be tested at a time. 
The aim of this thesis was to optimise methods and to develop a protocol for simultaneous detection 
of human intestinal parasites Giardia lamblia and Cryptosporidium spp. (C. parvum and C. 
hominis) from clinical stool samples in a high-throughput format. 
Methods: Human stool samples positive for Giardia lamblia or Cryptosporidium hominis were 
used to test different sample pretreatments (concentration methods, heat shocks, freeze-thaw cycles 
and proteinase treatments) and combinations to find the optimal one for maximal DNA release from 
the parasite (oo)cysts. Altogether 13 different protocols were tested. Three commercial DNA 
extraction kits were tested to find the best one for parasite DNA extraction. qPCR reaction was 
optimised first for primer and probe concentrations separately for both of the parasites and secondly 
these were combined into a multiplex reaction. DiabImmune study samples were tested for the two 
parasites after optimisation of methods and the functionality of qPCR reaction was confirmed for 
Cryptosporidium parvum too.  
Results: A pretreatment protocol consisting of a 10-minute heat shock at +98 °C and an overnight 
proteinase treatment at +56 °C was considered the best. The choice was made mostly based on the 
results of the Giardia lamblia sample, because the Cryptosporidium hominis sample showed 
constantly weak positivity. An extraction kit designed for viral RNA extraction was found the most 
effective. The differences in results obtained for different qPCR primer and probe concentrations 
were small and the concentrations were thus chosen cost-efficiently based on the lowest possible 
concentrations of the reagents. The Cryptosporidium spp. qPCR was found to detect both 
Cryptosporidium hominis and parvum. All DiabImmune samples collected from children 
representing background population were negative 
Conclusions: The protocol obtained as a result of this thesis is a reproducible, sensitive and high-
throughput method for the detection of these two intestinal parasites in human stool samples. Even 
though the Cryptosporidium hominis sample used for optimisation was only weakly positive, the 
functionality of detection was confirmed with a C. parvum-positive sample. As a result of this 
thesis, professor Heikki Hyöty’s laboratory has started using the optimised protocol for detection of 
Giardia lamblia and Cryptosporidium spp. in their research.  
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LN  liquid nitrogen 
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qPCR  quantitative polymerase chain reaction 
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SSU  small subunit 
VSP  variable surface protein 
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1. Introduction 
 
Diarrhoea was the fifth leading cause of death in low- and middle-income countries in 2008, 
accounting for approximately 5 % of deaths in total (WHO - mortality statistics, 2013). It was more 
common as a cause of death than HIV / AIDS in these countries. Certain viruses, bacteria or 
parasites cause these diarrhoeal diseases. In 2009, diarrhoea was reported the second leading cause 
of death in children under 5 years old, killing approximately 1,5 million children globally (WHO - 
diarrhoeal disease, 2013). 
 
Giardia lamblia and Cryptosporidium species (spp.) are the two major intestinal parasites causing 
diarrhoea (Caccio et al., 2005). They share some common characteristics, e.g. their major 
transmission happens by faecal-oral route, either directly or indirectly (Caccio et al., 2005). Direct 
route can be due to insufficient hand hygiene or person-to-person contacts, whereas indirect routes 
include consuming contaminated water or food. Zoonotic transmission is also possible, being more 
common with Cryptosporidium than Giardia (Caccio et al., 2005). The infective form of these 
parasites is an (oo)cyst (oocyst for Cryptosporidium, cyst for Giardia lamblia).  
 
These two parasites share the transmission mechanism and some other characteristics. Both have 
really low infectious dose: only 10 (oo)cysts might be enough to trigger an infection (Chen et al., 
2002). The (oo)cysts are immediately infectious after their formation and very stable due to their 
hard walls (Caccio et al., 2005). It has been shown that Cryptosporidium oocysts are tougher than 
Giardia lamblia cysts (Robertson and Gjerde, 2004). The (oo)cysts can survive in a latent form 
outside the body for months, taken that the location is damp enough (Sunnotel et al., 2006). They 
are resistant to virtually all traditional disinfectants and water purification systems. Furthermore, 
contaminated water requires filtration before use (Chen et al., 2002; Davies and Chalmers, 2009). 
On the other hand, some publications claim that filtration is not effective (Robertson and Gjerde, 
2007), but filter pore size might also play a role. In addition, according to Sunnotel et al. (2006), 
conventional water purification systems are sufficient to get rid of Cryptosporidium oocysts. 
Evidently, this subject is still under debate and more research is required to draw definite 
conclusions. 
 
Treatment options for both of these parasites are limited and ineffective: specific treatments are 
almost non-existent (Davies and Chalmers, 2009). Nitazoxanide, an anti-protozoal agent, is 
9 
sometimes used in immunocompromised Cryptosporidium patients to attenuate the symptoms and 
also for Giardia lamblia-infected adults in the USA (Davies and Chalmers, 2009; Sunnotel et al., 
2006). Other medicines used usually have a general anti-parasitic activity (Davies and Chalmers, 
2009). Some prospective new drugs, e.g. derivatives of benzimidazole are being studied for the 
treatment of Giardia lamblia, but these have so far been restricted to proof-of-principle and animal 
model studies (Tejman-Yarden and Eckmann, 2011). 
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2. Review of the literature 
 
2.1 Giardia lamblia and giardiasis 
 
Giardia lamblia is a eukaryotic, flagellated parasite, which taxonomically belongs to the phylum 
Metamonada, order Diplomonada and family Hexatimidae. It has seven genotypes (A-G), of which 
only the genotypes A and B cause disease in humans (Caccio et al., 2005). The different genotypes 
are phenotypically and genotypically quite heterogeneous, but morphologically almost identical 
within the species and thus impossible to distinguish by e.g. only microscopic examination (Caccio 
et al., 2005). 
 
For historical reasons, Giardia lamblia is known by various names in the literature: Giardia 
duodenalis, Giardia intestinalis and Lamblia intestinalis are all synonyms for the name Giardia 
lamblia used in this thesis.  
 
This parasite causes giardiasis, for which the main symptom is diarrhoea. The prevalence of the 
disease in developing countries is on average 20 % of the total population and on average 5 % in 
industrialised countries (Roxstrom-Lindquist et al., 2006). Risk factors for acquiring giardiasis 
include swimming in recreational pools (and ingesting the water), drinking contaminated tap water 
or eating food rinsed with it (Caccio et al., 2005). Zoonotic transmission is also possible, usually 
from dogs (Caccio et al., 2005).  Symptoms vary between different countries (Cotton et al., 2011) 
and depend on several factors such as age, nutritional status, Giardia genotype, coinfections and 
host immune status (Roxstrom-Lindquist et al., 2006; Solaymani-Mohammadi and Singer, 2010). 
Immunocompetent individuals usually tend to be asymptomatic or have only mild symptoms, 
whereas immunocompromised individuals (e.g. HIV patients) are more likely to develop chronic 
diarrhoea (Roxstrom-Lindquist et al., 2006). Other symptoms include abdominal pain, vomiting and 
bloating.  
 
Long-term effects of giardiasis can include malabsorption, allergies and growth problems in 
children (Caccio et al., 2005). Furthermore, giardiasis may cause symptoms in other parts of the 
body (e.g. joints, muscles, eyes and skin) even though the parasites stay exclusively in the 
gastrointestinal tract (Cotton et al., 2011). The reasons for these symptoms are not known. 
Giardiasis is also known to be able to trigger irritated bowel syndrome (IBS) (Cotton et al., 2011), 
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although it usually does not trigger mucosal inflammation, probably because the parasites do not 
invade the cells of the intestinal tract (Figure 1) (Roxstrom-Lindquist et al., 2006; Solaymani-
Mohammadi and Singer, 2010). 
 
Giardia lamblia’s lifecycle is extracellular at all phases (Roxstrom-Lindquist et al., 2006). The 
cysts have to be ingested, after which they travel to the upper small intestine (Roxstrom-Lindquist 
et al., 2006) where the thick walls are broken down presumably with the help of bile salts, proteases 
and lipases. This phase is called excystation (Figure 1). The released excyzoites differentiate into 
trophozoites which in turn start to replicate (Roxstrom-Lindquist et al., 2006). Once a certain 
threshold is surpassed, the symptoms are induced. The trophozoites adhere to the epithelia of the 
small intestine via an adherent disk (Cotton et al., 2011) and they have to constantly detach and 
reattach to avoid elimination by peristalsis (Roxstrom-Lindquist et al., 2006). In the next step, the 
trophozoites either disintegrate (Figure 1) or encyst to form new cysts, which are excreted with the 
faeces. Some trophozoites might also be excreted, but they are not viable outside the body.  
 
The disease mechanism of giardiasis is still under debate. Shortening of the microvilli has been 
found in some patients, which could in turn explain the malabsorption symptoms often found in 
giardiasis (Cotton et al., 2011; Solaymani-Mohammadi and Singer, 2010). Increased transit rates, 
chloride hypersecretion and rearrangements of the host epithelial cell cytoskeletal actin network 
have also been reported (Cotton et al., 2011; Roxstrom-Lindquist et al., 2006). In addition, 
breakdown of the apical tight junctions between intestinal epithelial cells and increased apoptosis 
rates of these cells have been found (Cotton et al., 2011). 
 
Some epidemiological studies have shown that previous Giardia lamblia infections are related to a 
reduced risk of re-infection and milder symptoms in such cases (Solaymani-Mohammadi and 
Singer, 2010). It has been established that the immune response against Giardia lamblia includes 
both innate and adaptive responses (Solaymani-Mohammadi and Singer, 2010), and that the 
variable surface proteins (VSPs) are the major antigens (Roxstrom-Lindquist et al., 2006), but the 
details of the aforementioned immune mechanisms are still not clear.  
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2.2 Cryptosporidium spp. and cryptosporidiosis 
 
Cryptosporidium is a eukaryotic parasite that taxonomically belongs to the phylum Apicomplexa, 
order Eucoccidiorida and family Cryptosporidiidae. In humans, C. parvum and C. hominis are the 
most common forms (Caccio et al., 2005), but also C. muris, C. meleagridis and C. felis can infect 
humans (Chen et al., 2002). It seems that C. parvum has remained zoonotic and is often acquired 
from farm animals whereas C. hominis is quite strictly constricted to humans and is acquired 
usually via contaminated water or food (Davies and Chalmers, 2009; Robertson and Gjerde, 2007; 
Sunnotel et al., 2006). The prevalence of the different species varies geographically (Chen et al., 
2002). However, the ones occurring more rarely could in fact be less pathogenic and asymptomatic 
and thus be frequently undiagnosed compared to the more pathogenic ones (Davies and Chalmers, 
2009). 
 
The Cryptosporidium spp. cause a disease called cryptosporidiosis. Its prevalence is on average 10 
% of the total population in developing countries and on average 1-3 % in industrialised countries 
(Chen et al., 2002). As with giardiasis, cryptosporidiosis is more common in immunocompromised 
Figure 1. Diagram of Giardia lamblia’s life cycle. (source: modified 
from http://www.idexx.com/view/xhtml/en_us/smallanimal/ 
education/reference-library/giardia.jsf; 3.5.2013)  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individuals while infection is usually asymptomatic or mild in the immunocompetent ones. 
Zoonotic transmission is possible, usually from cattle (Caccio et al., 2005). What applies to Giardia 
lamblia, also applies to Cryptosporidium spp.: The parasites of the different species are 
phenotypically and genotypically heterogeneous, but morphologically almost identical (Caccio et 
al., 2005; Nichols et al., 2006).  
 
Risk factors of cryptosporidiosis include age of the patient (very young or old being the most 
susceptible ones), travelling abroad and contacts with a person or a farm animal with 
cryptosporidiosis (Caccio et al., 2005; Chen et al., 2002). Symptoms are partly the same as in 
giardiasis: Diarrhoea is the main symptom, but vomiting and abdominal pain are also common 
(Chen et al., 2002). Apoptosis of neighbouring cells of the infected intestinal epithelial cell causes 
malabsorption and enhanced secretion; another suggested cause for the latter is an enterotoxin 
secreted by the parasite, but this is not widely verified yet (Chen et al., 2002). Symptoms of 
cryptosporidiosis can also be extraintestinal: Middle ear, pancreas and biliary tract can be infected, 
the latest being the most common one. How and why these aforementioned conditions occur is not 
known, but they are mostly observed in AIDS patients (Chen et al., 2002). Furthermore, lungs can 
be infected, because airborne transmission is possible for Cryptosporidium spp. (Caccio et al., 
2005). 
 
Cryptosporidium’s lifecycle is mainly intracellular but extracytoplasmic (Figure 2) (Chen et al., 
2002). After the oocysts are ingested, they travel to the small intestine and excyst as a response to 
e.g. changed pH, producing infective sporozoites (Robertson and Gjerde, 2007). These attach to the 
epithelia. The epithelial cell in question forms a vacuole around the parasite, which however does 
not get totally endocytosed. In this vacuole, the parasite matures and undergoes asexual 
reproduction into type I meront that can either release merozoites to infect other cells or mature into 
a type II meront (Figure 2) (Chen et al., 2002). Type II meronts can in turn mature into gametocytes 
and start the sexual part of the life cycle. Gametocyte can either be a macro- or microgametocyte 
and the microgametes produced by the latter one fertilise the first mentioned (Figure 2) (Sunnotel et 
al., 2006). As a result, a zygote is formed and it undergoes encystation into an oocyst, which is 
excreted with the faeces. 
 
Cryptosporidium has the ability to rearrange the cytoskeleton of its host by using actin-
polymerising factors (Sunnotel et al., 2006). At the base of each vacuole, formed by these 
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cytoskeletal elements, is an electron-dense band which the parasite probably uses to take nutrients 
from the host (Chen et al., 2002). 
 
Unlike Giardia lamblia, Cryptosporidium causes an inflammation reaction in the intestine (Chen et 
al., 2002). The inflammation affects only the most superficial epithelial surface of the mucosa. The 
mechanisms are not well known, however production of inflammatory cytokines can be involved in 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Diagram of Cryptosporidium’s life 
cycle. (source: modified from Sunnotel et al. 
(2006)  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the process. It is also possible to acquire resistance against re-infections of Cryptosporidium and 
interferon γ seems to have an important role in this phenomenon (Chen et al., 2002). 
Cryptosporidium is also said to be able to trigger IBS, but this is still under debate (Davies and 
Chalmers, 2009). 
 
2.3 Proposed connection between intestinal parasite infections and allergic diseases 
 
Already from the very first months of human life, the immune system is broadly stimulated by 
different microorganisms (Olszak et al., 2012). The gastrointestinal tract and lungs are especially 
vulnerable, because they are the primary “landing sites” for the microbes. Furthermore, the gut and 
the barrier it forms are immature and quite permeable to different microbes to enter the body during 
infancy (Rautava et al., 2004). These early contacts (or the lack of them) may have a life-long 
influence on whether the person in question will get an allergic or an autoimmune disease (e.g. 
multiple sclerosis or type 1 diabetes) (Olszak et al., 2012).  
 
Allergic diseases are an emerging problem in industrialised countries. In an allergic disease (e.g. 
asthma), seemingly innocuous antigens trigger a T-cell-mediated systemic inflammation 
(Romagnani, 2004). The causes are both genetic and environmental (Romagnani, 2004). Allergic 
diseases have been linked to decreased exposure to different pathogens and allergens, which in turn 
has raised a question about the possible role of the so-called hygiene hypothesis in the onset of 
these diseases (Ramsey and Celedon, 2005; Seiskari et al., 2007). The hygiene hypothesis suggests 
that exposure to different microorganisms during childhood protects from allergic diseases later in 
life due to the promoted maturation of the immune system (Yazdanbakhsh and Matricardi, 2004). 
One possible explanation for this is that early encounters with multiple microorganisms prevent e.g. 
the gastrointestinal tract from being colonised by harmful microbes. Alternatively, the exposure to 
diverse microorganisms might divert the immune system in such a direction that counteracts the 
development of allergic diseases (Ege et al., 2011). 
 
Previously, these diseases along with several autoimmune diseases have been linked to 
gastrointestinal parasitic infections (Yazdanbakhsh and Matricardi, 2004). Some parasites (e.g. 
Toxoplasma gondii, some helminths) have been found to be protective against these diseases 
whereas some (e.g. Campylobacter jejuni) are evidently predisposing (Ramsey and Celedon, 2005; 
Rautava et al., 2004; Seiskari et al., 2007). However, there are some inconsistencies between 
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different studies regarding these implications and sometimes other already existing diseases have an 
alternating effect on the results (Ramsey and Celedon, 2005). 
 
2.4 DiabImmune study description 
 
DiabImmune (complete title of the project: “Pathogenesis of type 1 diabetes: testing the hygiene 
hypothesis”) is a large, international collaboration project which aims to define the mechanisms of 
hygiene hypothesis in the pathogenesis of autoimmune and allergic diseases. Another objective is to 
assess the links between improved standard of hygiene and increased incidence of these diseases.  
 
At the border of Finland and Russian Karelia, there is a significant gradient in the standard of 
living. For example, the gross national product per capita of Russian Karelia is only one seventh of 
that of Finland. On the other hand, there are no significant differences in the mean temperatures or 
other physical factors, or in the background population regarding for example the distribution of the 
human leukocyte antigen (HLA) genotypes, which are used to assess predisposition to many 
autoimmune diseases. For these reasons, Finland and Russian Karelia represent a productive 
environment for studying gene-environment interactions in the pathogenesis of immune-mediated 
diseases. Estonia is included in the project because of its geographical location. It also represents a 
country that is undergoing a rapid transition. Furthermore, previous studies have shown that there 
are large differences in the occurrence of different microbes between these three areas (Viskari et 
al., 2004). For these reasons Estonia can be used as additional population of comparison.  
 
In DiabImmune project, several different sample types (e.g. blood and stool samples) are collected 
from large cohorts of children in Finland, Russian Karelia and Estonia. One cohort comprises 
children that are assessed at the ages of 3 and 5 years. The second one is a birth cohort, in which the 
children are monitored from birth to the age of 3 years. The children are analysed for type 1 
diabetes –associated autoantibodies and allergen-specific IgE-class antibodies, as well as for 
different infections, gene-expression profiles and nutritional factors. The different research groups 
participating in the study work in collaboration to bring new information about the connections 
between microbial exposure and allergic and autoimmune diseases. 
 
The stool samples collected for DiabImmune study will be used in this thesis to test the optimised 
protocols for the possible presence of Cryptosporidium spp. and/or Giardia lamblia.  
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2.5 Theoretical background of the methods 
 
Infections by Giardia lamblia and Cryptosporidium spp. are diagnosed by detecting (oo)cysts from 
stool samples. In most diagnostic laboratories around the world, stool sample microscopy is still the 
golden standard of detection for Giardia lamblia and Cryptosporidium spp. (Elwin et al., 2012; 
Schuurman et al., 2007). Usually multiple stool samples over time have to be tested, because 
(oo)cysts or trophozoites are not excreted constantly. However, microscopy as a technique has 
many drawbacks: It is time-consuming, labour-intensive, expensive and the results depend partly on 
the subjective observation (Schuurman et al., 2007; Verweij et al., 2003). Sensitivity of the 
technique is also a problem, because single (oo)cysts are difficult to detect.  
 
ELISA, other immunoassays and qPCR can also be used for the detection of parasites (Schuurman 
et al., 2007; Verweij et al., 2003). However, antibody-based techniques can occasionally be non-
specific due to cross-reactivity and have low sensitivity (Verweij et al., 2004). qPCR is thought to 
be more sensitive than microscopy, but it also has a cross-contamination risk. In addition, 
sensitivity depends on the system used: One Giardia lamblia cyst contains approximately 313 fg of 
chromosomal DNA (Schuurman et al., 2007) and not all qPCR systems detect such a small amount. 
 
The goal of this thesis was to develop new methods for the detection of these infections aiming at a 
high-throughput format, which would enable effective screening of large sample series. The 
practical aim was to use the same pretreatments and other assay steps for both Giardia lamblia and 
Cryptosporidium spp., despite that in several previous publications different protocols have been 
used separately for different parasites.  
 
2.5.1 Stool sample pretreatments 
 
Stool samples usually require pretreating before they can be used to diagnose microbial agents, 
because they contain a lot of impurities (such as food degradation products and lipids) and 
inhibitors, which can affect downstream applications (Nantavisai et al., 2007). To overcome this 
problem, many publications have described stool sample pretreatments where so-called “spiked” 
stool samples have been used, meaning that purified (oo)cysts have been added to originally 
negative stool samples (Ng et al., 2005; Stroup et al., 2012). Alternatively, only prepurified 
(oo)cysts have been used to study wall disruption methods in several publications (Guy et al., 2003; 
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Minarovicova et al., 2009). Soil or sewage have also been used as sample material (Bertrand et al., 
2004; Guy et al., 2003). 
 
Since the amount of (oo)cysts in a stool sample of an infected individual is often very low (Chen et 
al., 2002) concentration step has been used in many protocols including simple centrifugation  
combined with pellet resuspension as well as PBS-ether-Percoll –method, which is based on 
sedimentation in discontinuous density gradient (Adamska et al., 2012; Haque et al., 2007)  
 
In this thesis the focus is in different methods which are needed to disrupt the (oo)cyst wall. As 
mentioned before, the (oo)cyst wall is very tough, probably because of the cysteine- and disulfide-
bond-rich VSP proteins that form it (Adamska et al., 2011; Roxstrom-Lindquist et al., 2006). The 
wall must be disrupted to access the DNA, which is used for downstream applications. Due to the 
vast selection of different methods, the present work focuses on those methods which are 
technically the most feasible for the aims of this study. 
 
2.5.1.1 Freeze-thaw cycles 
 
Freeze-thaw cycles with various lengths, repetition times and temperatures have been used in 
previous studies to disrupt the (oo)cysts’ wall. Their use is based on the idea that repeated 
temperature changes cause shearing forces on the (oo)cyst wall, thus leading to its destruction and 
consequently making the DNA accessible for extraction (Robertson and Gjerde, 2004). In most 
publications, the highest temperature varies from +95 °C to +100 °C and the lowest temperature is 
usually achieved by liquid nitrogen (LN; -196 °C) (Adamska et al., 2011; Haque et al., 2007). 
Adamska et al. (2011) noticed in their study that -70 °C was not cold enough in the freeze-thaw 
cycling, because positive samples were negative in PCR detection. The length of the freeze-thaw 
cycling phases is usually 1-2 minutes (Fontaine and Guillot, 2002; Nichols et al., 2006) and the 
cycles are repeated 3 to 15 times (Adamska et al., 2011; Nichols et al., 2006). As can be seen from 
these examples, there is plenty of variation between published protocols. In addition, the execution 
varies; heating can for example be achieved with a water bath or a heat block (Adamska et al., 
2011). 
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2.5.1.2 Heat shocks 
 
Heat shocks of varying temperatures are one possible (oo)cyst wall disruption method. These 
usually only inactivate the (oo)cysts (Minarovicova et al., 2009) and for this reason they are not 
effective alone. Thus, heat shocks are usually combined with other steps, such as a proteinase 
treatment (see the next chapter) (Minarovicova et al., 2009; Verweij et al., 2003). In most 
publications heat shock refers to an incubation step at approximately +95 °C for 10-20 minutes, 
though Sunnotel et al. (2006) claim that any temperature above +65 °C is enough to destroy the 
oocysts of Cryptosporidium.   
 
2.5.1.3 Proteinase treatments 
 
Proteinases have been used to disrupt parasite wall using different incubation periods (ranging from 
1 h to overnight) at approximately +56 °C (Minarovicova et al., 2009). Proteinases are very 
effective for Cryptosporidium spp., detaching the separate layers of the oocyst wall from each other 
(Adamska et al., 2011). Additional steps are often combined with the proteinase treatments, such as 
heat shocks (see chapter 2.5.1.2) or freeze-thaw cycles (see chapter 2.5.1.1), but the proteinase 
treatment has always been the last step of pretreatments (Nichols et al., 2006). Some publications 
also suggest that the proteinase reaction should be stopped by an incubation for approximately 15 
minutes at +95 °C (Minarovicova et al., 2009) since the proteinase activity might inhibit some 
downstream applications. 
 
2.5.2 DNA extraction 
 
Nowadays commercial kits are widely used for routine DNA and/or RNA extraction. Different kits 
usually follow the same principles: First the nucleic acids are bound to a porous filter of a column, 
the sample is washed and subsequently eluted. The differences are usually in the incubation times, 
the centrifugation parameters and in specific reagents used. In this thesis, different Qiagen (Hilden, 
Germany) kits were tested. These kits were chosen based on previous literature (Adamska et al., 
2011; Guy et al., 2003; Haque et al., 2007) and the kits already in use in Heikki Hyöty’s laboratory. 
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2.5.3 qPCR and its use as a pathogen detection method 
 
PCR is a method for DNA amplification. Conventional PCR has three phases including 
denaturation, annealing and extension (McPherson and Moller, 2000). In denaturation phase, the 
double-stranded template DNA is heated to a temperature where the two complementary strands 
separate. Next, in the annealing phase, the temperature is lowered so that the sequence-specific 
primers hybridise to their complementary target DNA sequences at the template and DNA 
polymerases start the extension from the 3’ end of the primers (McPherson and Moller, 2000). At 
the extension phase the temperature is optimal for the DNA polymerase to work and the extension 
continues. These three steps are repeated for a certain number of times, usually 35-45 cycles, 
depending on the application. Sometimes the annealing and extension steps can be combined, as is 
done in this thesis. 
 
The PCR reaction requires different reagents. In this case, a ready-made master mix of the kit 
includes most of these reagents. It includes the thermostable Taq DNA polymerase that performs 
the actual DNA amplification. The DNA polymerase used in this thesis is of a modified form 
(HotStarTaq DNA polymerase) which is inactive in room temperature and has to be activated in the 
first step of the PCR reaction. This activation step reduces the amount of nonspecific PCR products. 
The master mix also includes buffer that is required to create optimal conditions for the reaction. 
This buffer is composed of NH4+ and K+ ions and MgCl2. The two ions promote specific primer 
annealing and inhibit nonspecific binding and MgCl2 affects the stringency of the primer-template 
interaction. Furthermore, the master mix includes a dNTP mix which has equivalent amounts of all 
four nucleotides that are used in the PCR reaction to synthesise the PCR products. Finally, this 
qPCR master mix includes a passive 6-carboxy-X-rhodamine (ROX) reference dye which is used as 
a baseline in the reaction. 
 
qPCR is used both for DNA amplification (as conventional PCR) and for real-time monitoring of 
the amount of synthesized amplicons (McPherson and Moller, 2000). There are several ways to 
detect the amplification products. The conventional ones include for example SYBR Green or 
ethidium bromide, but they bind to all double-stranded DNA (dsDNA) present in the reaction tube, 
which excludes them from being used for diagnostic purposes (McPherson and Moller, 2000). 
Nowadays also fluorescence-based systems exist. The two most used ones are the TaqMan system 
and the two-probe system (fluorescence resonance energy transfer, FRET). Only the TaqMan 
system will be described here, for it is the one used in this thesis. 
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The TaqMan system uses, in addition to primers, an oligonucleotide probe that has a fluorophore 
reporter moiety at the 5’ end and a quencher moiety at the 3’ end (Figure 3). These moieties have an 
overlap in their emission and excitation spectra, thus making the fluorophore reporter unable to emit 
a detectable fluorescent signal at the presence of the quencher (McPherson and Moller, 2000). This 
probe is designed to hybridise to a complementary segment of the template DNA (downstream of 
the 5’ primer), but as mentioned before, as long as the quencher is bound to the other end of the 
same probe, the fluorophore moiety is not able to emit a fluorescent signal, regardless if it is bound 
to the target. During the extension phase of the PCR cycle, as the Taq DNA polymerase reaches the 
site where the probe is bound, it cleaves and thus liberates the 5’ fluorophore reporter moiety of the 
probe with its 5’  3’ exonuclease activity. This leads to a detectable fluorescent signal (Figure 3) 
(McPherson and Moller, 2000). The amount of the specific PCR product is proportional to the 
amount of fluorescence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Diagram of the principle of qPCR using the TaqMan system. 
(source: modified from McPherson and Moller (2000) 
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The ABI 7900HT qPCR machine does both the thermal cycling and fluorescence detection and also 
the measurements. The machine is connected to a computer with SDS software. It uses the ROX 
dye fluorescence to normalise the PCR product-related fluorescence signals. A baseline for the 
qPCR reaction is calculated based on the fluorescence acquired from the PCR products and it is 
reckoned the noise level of the early cycles when there is not yet detectable fluorescence from the 
amplification products (Figure 4) (QIAGEN - Data analysis 2013). The software produces a 
sigmoidal-shaped amplification plot (when using a linear scale, Figure 4), where the amount of 
detected fluorescence is plotted against the cycle number. The threshold is set to value above the 
baseline, but in the log-linear range of the plot. The threshold cycle (CT) values are determined 
using this threshold: a CT value indicates the reaction cycle at which the amplification plot crosses 
the set threshold (Figure 4) (QIAGEN - Data analysis 2013). The higher the CT value, the lower the 
starting amount of the template: in Figure 4, sample A contains more starting template than sample 
B. CT values above 36 cycles are generally considered poorly reproducible and thus unreliable for 
e.g. parasite detection (ten Hove et al., 2007). An increase of approximately 3,5 cycles indicates a 
10-fold decrease in the amount of the template in the original sample. 
 
Figure 4. A qPCR amplification plot. (source: QIAGEN - Data analysis 2013) 
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qPCR is a powerful and worthy tool for parasite detection. It is based on the detection of the 
presence of parasite DNA in the samples. It is also possible to combine the detection of different 
parasites to one reaction in multiplex qPCR. Usually the combination of different primers in same 
PCR reaction tends to slightly inhibit each other, a phenomenon also known as “multiplex 
interference” (Hlousek et al., 2012). The benefit is still obvious, because working time and reagents 
can be saved and more analyses can be run with the machine. The main problem in using qPCR for 
parasite detection from stool samples is the presence of inhibitors that need to be removed 
beforehand (Abu Al-Soud and Radstrom, 2000). BSA is widely used for reduction of the inhibition 
in the PCR, but some publications claim it is useful only in the conventional PCR (Abu Al-Soud 
and Radstrom, 2000). Another problem is that often the stool samples are formalin-fixed. Formalin 
is used as sample preservative, but it is known to denaturate DNA, which partly inhibits e.g. qPCR 
reactions (Paglia and Visca, 2004; Srinivasan et al., 2002).  
 
For Giardia lamblia, the small subunit (SSU) rRNA sequence is widely used in qPCR detection 
(Verweij et al., 2003) and it was also used in this thesis. For Cryptosporidium spp. detection, 
DNAJ-like gene was used (Bruijnesteijn van Coppenraet et al., 2009). 
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3. Main goals of the thesis 
 
The main goals of this thesis were to optimise methods and to derive a protocol to detect human 
intestinal parasites Giardia lamblia and Cryptosporidium spp. (C. parvum and C. hominis) from 
clinical stool samples. These optimisations aimed at a protocol that can be used in a high-
throughput format to screen large samples series in studies evaluating the possible links between 
allergic diseases and the aforementioned parasitic infections. 
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4. Materials and methods 
 
4.1 Samples 
 
Optimisation was carried out using clinical, formalin-fixed stool samples found positive for Giardia 
lamblia or Cryptosporidium spp. using traditional microscopic examination. Four Cryptosporidium-
positive samples were obtained from the UK Cryptosporidium Reference Unit (CRU; Public Health 
Wales Microbiology ABM, Singleton Hospital, Swansea, UK). Three of them were positive for C. 
hominis and one for C. parvum. One of the C. hominis-positive samples was chosen for testing 
based on preliminary results (results not shown).  The Giardia lamblia-positive sample was 
provided by the Fimlab Laboratories (Pirkanmaa Hospital District).  
 
The stool samples were suspended into Hank’s buffer (Table S1, Appendix 1), which was 
supplemented with 4 % BSA (20 g of albumin (Sigma-Aldrich, Europe) in 500 ml of Minimum 
Essential Medium with Earle´s Salts, without L-Glutamine (PAA Laboratories, Pasching, Austria)). 
Stool samples were suspended to enable DNA extraction with Qiagen kits. Approximately 300 mg 
of stool was suspended into 3 ml of this buffer. The suspensions were stored in -20 °C. 
 
4.2 Stool sample pretreatments 
 
In the previuos literature, several different sample pretreatment techniques and their combinations 
have been tested to improve Cryptosporidium spp. and Giardia lamblia detection in human stool 
samples by PCR-based methods (Adamska et al., 2011; Haque et al., 2007). In this study, multiple 
different methods were tested including one with no pretreatments. In addition, sterile water 
samples were included as negative controls in every test. Summary of the methods and 
combinations is presented in Table 1. 
 
4.2.1 Concentration methods 
 
To test whether the (oo)cysts pellet during centrifugation, a stool suspension was centrifuged at 
1118 g for 30 minutes at +4 °C (without braking). Another sample was treated without 
centrifugation. Pellet resuspension was also tested as a concentration method for Cryptosporidium 
hominis: the pellet obtained from the centrifuged sample was suspended into 500 µl of the 
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aforementioned stool suspension solution (Table 1, protocol 1). Furthermore, sedimentation was 
tested as a gentler alternative to centrifuging. The stool suspension was left at the laminar to 
sedimentate for 1 hour and the supernatant was transferred to a new tube. This was repeated once 
and the final supernatant was used for downstream reactions (Table 1, protocols 1-7). 
 
4.2.2 Freeze-thaw cycles 
 
200 µl of stool suspension was incubated on a heat block of +100 °C for 2 minutes and 
subsequently freezed in a closed container of LN for 2 minutes. These two stages were repeated for 
a different number of times: once, three times or ten times (Table 1, protocols 5-7 and 11-13).  
 
4.2.3 Heat shocks 
 
Heat shocks were carried out by incubating 200 µl of stool suspension on a heat block of +98 °C for 
10 minutes. These heat shocks were used in combination with different proteinase treatments (Table 
1, protocols 1-3 and 8-10).  
 
4.2.4 Proteinase treatments 
 
Proteinase treatments were executed with proteinase K (cat. no. 19133; Qiagen, Hilden, Germany). 
15 µl of proteinase K was added to 200 µl of stool suspension, which was then incubated at +56 °C 
on a heat block for 2 hours, 3 hours or overnight (o/n). The proteinase treatments were combined to 
a heat shock or freeze-thaw cycles (Table 1, protocols 1-13).  
 
4.3 DNA extraction 
 
The DNA extraction was carried out using commercial kits from Qiagen (Hilden, Germany): three 
different kits were tested. The kits were chosen based on literature and the laboratory’s own 
facilities: QIAamp DNA Blood Mini Kit (later on ‘blood kit’, cat. no. 51104) (Guy et al., 2003), 
QIAamp DNA Stool Mini Kit (later on ‘stool kit’, cat. no. 51504) (Babaei et al., 2011; Haque et al., 
2007) and QIAamp Viral RNA Mini Kit (later on ‘viral kit’, cat. no. 52906).  
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The kits were tested by performing a sample elution series of 10-1 to 10-6 of a non-pretreated 
Giardia lamblia sample. The most suitable kit was chosen based on sensitivity of the qPCR 
method. This testing was done in single tubes and columns and the optimised DNA extraction 
method was adapted onto 96-well plate system. The extracted DNA samples were either used 
immediately in the proceeding steps or stored in -20 °C.  
 
Table 1. Summary of the tested stool sample pretreatments. 'x' indicates that the step was 
included in the protocol. In the last two lines it indicates which protocols were implemented 
for each parasite.  
   protocol number 
 pretreatment 1 2 3 4 5 6 7 8 9 10 11 12 13 
 pellet resuspension x                         
 sedimentation x x x x x x x             
heating 10 min +98 °C x x x         x x x       
2h +56 °C x             x           
3h +56 °C   x             x         proteinase treatments 
o/n +56 °C     x x x x x     x x x x 
1x         x           x     
3x           x           x   
freeze- 
thaw 
cycles 10x             x           x 
                             
Cryptosporidium 
hominis x x x x x x x x x x   x   tested for 
Giardia lamblia     x   x x x x   x x x x 
 
Some modifications were made on the kit protocols. The DNA extraction with viral kit was 
performed with combination of the viral kit reagents and RNEasy columns according to Heikki 
Hyöty’s laboratory’s routine practice. Also, the extraction with the stool kit was tested both with 
and without the InhibitEx tablets included in the kit.  
 
4.4 qPCR 
 
The qPCR was performed with Applied Biosystems ABI 7900HT machine (LifeTech, Paisley, UK). 
The primer and probe sequences were selected from literature. These oligonucleotides had already 
been tested and shown to be specific and sensitive in previous publications. The Giardia lamblia-
specific primers and probe were targeted to SSU rRNA gene of the parasite (GenBank accession no. 
M54878) to amplify and detect a 62-bp DNA fragment (Verweij et al., 2004). The Cryptosporidium 
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spp.-specific primers and probe were targeted to amplify and detect 70 bp fragment of the DNAJ-
like protein gene (GenBank accession no. AF177278.1 / XM661034.1) (Bruijnesteijn van 
Coppenraet et al., 2009). The sequences of the primers and probes are shown in Table 2. The 
primers were ordered from Sigma-Aldrich (Europe) and the probes from AB Applied Biosystems 
(LifeTech, Paisley, UK). The primers and probes chosen for Cryptosporidium spp. recognise both 
Cryptosporidium parvum and Cryptosporidium hominis, because it was not necessary to distinguish 
the two species. The qPCR was conducted with QuantiTect Probe PCR kit (cat. no. 204345; 
Qiagen, Hilden, Germany). 
 
Table 2. Primers and probes used for qPCR. The abbreviations in the 5’ end and 3’ end of the 
probe sequences stand for the fluorescent dye and quencher moiety, respectively. ‘FAM’ 
stands for fluorescein amidite, ‘MGB’ stands for minor groove binder and ‘VIC’ is a 
proprietary name of Lifetech. The primers and probes for Giardia lamblia are from the 
publication (Verweij et al., 2004). The Cryptosporidium spp. oligonucleotides are from the 
publication (Bruijnesteijn van Coppenraet et al., 2009) with the exception that the fluorescent 
dye of the probe was changed from NED to VIC for technical reasons; ‘NED’ being a 
proprietary name of Lifetech.       
 
 
 
The qPCR reactions were optimised for primer and probe concentrations according to the 
instructions of the qPCR kit and concentrations of 400-1000 µM for primers and 100-200 µM for 
probes were tested. The total reaction volume was decreased from the directive 50 (25) µl to 10 µl, 
because this reaction volume was already tested in the research group and it saves reagents. The 
volume of template sample was increased from the laboratory’s directive 0,8 µl to 2,0 µl (in 10 µl 
reaction) to ensure sufficient template amount in the reaction. Reactions for both parasites were first 
optimised separately as singleplex reactions and then combined to one, multiplex reaction.  
 
Giardia lamblia       
Forward primer GAC GGC TCA GGA CAA CGG TT 
Reverse primer TTG CCA GCG GTG TCC G 
Probe FAM - CCC GCG GCG GTC CCT GCT AG - MGB 
    
Cryptosporidium spp.       
Forward primer  CTT TTT ACC AAT CAC AGA ATC ATC AGA  
Reverse primer TGT GTT TGC CAA TGC ATA TGA A  
Probe VIC - TCG ACT GGT ATC CCT ATA A - MGB 
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The programme of the reaction (same for both singleplex and the multiplex reactions) is shown in 
Table 3, according to the instructions of the qPCR kit.  
 
        Table 3. The qPCR programme used for all qPCR reactions.   
 
 
 
 
 
The threshold value used for the analysis of the qPCR data was the default value of 0,20 set by the 
software. 
 
4.5 Testing of the optimised protocols 
 
Clinical stool samples (n = 174) of the DiabImmune study were tested with the optimised protocols. 
The test was conducted in triplicate reactions. These samples were from Estonian and Finnish 
children representing background population and were all under two years of age. The samples had 
been stored in -70 °C until used. Sterile water samples were included as negative controls and 
samples positive for Giardia lamblia and Cryptosporidium hominis were included as positive 
controls. 
 
The Cryptosporidium spp. qPCR should detect both C. parvum and C. hominis and this was tested 
with purified DNA samples of the parasites provided by the CRU. The optimised protocol was 
tested with a positive sample that was acquired from HUSLAB (Helsinki and Uusimaa Hospital 
District), during an epidemic of Cryptosporidium parvum. This sample was tested from 
resuspended pellet and supernatant. 
 
4.6 Data analysis 
 
The results of the qPCR runs were obtained from the SDS software (version 2.2.2) and used to rank 
the pretreatments, alternative kits in DNA extraction and qPCR reagent concentrations. The results 
are presented with average CT values and sample standard deviations (SD). 
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5. Results  
The laboratory work of this thesis consisted of four major parts: Optimisations of stool sample 
pretreatments, DNA extraction and qPCR reaction steps and use of optimised methods for the 
detection of parasites in stools samples collected in DiabImmune project. 
 
The optimisation of pretreatments and DNA extraction were tested using qPCR based on the qPCR 
kit’s basic protocol. Later the qPCR method was optimised to achieve the best possible sensitivity. 
All samples were tested by two or three parallel qPCR reactions. The qPCR results are presented in 
this thesis as average CT values of two or three tests and SD’s. 
 
5.1 Stool sample pretreatments 
 
There were clear efficacy differences between different stool sample pretreatments, especially when 
tested for the Giardia lamblia sample. The freeze-thaw cycles decreased the sensitivity of DNA 
extraction (Table 4; compare protocols 5-7 and 11-13 with protocols 3 and 10, respectively). 
Furthermore, the freeze-thaw cycles were very laborious. The 10-minute heat shock at +98 °C 
provided optimal results being a part of two of the tested protocols (Table 4, protocols 3 and 10). 
 
The proteinase K treatment at +56 °C was tested with incubation time of two hours, three hours and 
overnight. For the Giardia lamblia sample an overnight treatment (Table 4, protocols 3, 5-7 and 10-
13) was more efficient than the two-hour treatment (Table 4, protocol 8) Sedimentation as a 
concentration step had a very small, if any effect on the Giardia lamblia results. Protocols 3 and 5-7 
show only slightly stronger template amplification than protocols 10-13 (Table 4). 
 
Testing of the Cryptosporidium hominis sample proved to be challenging, because the stool 
suspension contained only low concentration of Cryptosporidium hominis DNA. Due to that, only 
the most optimal pretreatments released enough target DNA for positive qPCR detection. Some of 
the pretreatment methods did not work or they were not effective enough (e.g. freeze-thaw cycles) 
and for these reasons negative results or very weak qPCR signals were obtained. Nevertheless, two 
protocols (Table 4, protocols 1 and 10) showed clearly detectable and reproducible template 
concentrations.  
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Concentration of original Cryptosporidium hominis sample was low, but centrifugation 
concentrated the oocysts and resuspension of the pellet increased the detection of Cryptosporidium 
hominis (results not shown). Using this pretreatment the sample was constantly positive in qPCR 
(Table 4, protocol 1). Sedimentation did not improve the results much, compared to non-
sedimentated samples (Table 4; compare protocols 5-7 with protocols 11-13). Based on the results, 
the optimal protocol includes a 10-minute heating step at +98 °C and an overnight proteinase 
treatment at +56 °C (Table 4, protocol 10). 
 
Stool samples with no pretreatments were tested with Giardia lamblia sample (Table 5). With the 
viral kit, the template amplification was the strongest and at approximately the same level as with 
the protocols 5-7 (Table 4). 
 
5.2 DNA extraction 
 
The viral kit was the most sensitive of the tested nucleic acid extraction methods. The same dilution 
series were extracted using viral, blood and stool kits and the qPCR amplification of extracted 
nucleic acid was strongest from extracts provided by the viral kit (Table 5). In addition, the viral kit 
already has a ready-made 96-well protocol, which supported its choice of being the most suitable 
kit for DNA extraction in professor Hyöty’s laboratory. Only this kit was used for the optimisation 
of the stool sample pretreatments and for the upcoming testing. 
 
5.3 qPCR 
 
Different primer and probe concentrations did not increase the sensitivity of either Giardia lamblia-
specific or Cryptosporidium spp.-specific qPCR detection. The concentrations used in the 
subsequent reactions were thus chosen cost-efficiently based on the lowest possible concentrations 
of the reagents. The primer pair in concentrations of 700/700 nM (forward/reverse; Fwd/Rev) was 
selected for Giardia lamblia and the primer pair in concentrations of 400/400 nM (Fwd/Rev) for 
Cryptosporidium spp. (Table 6). The tested probe concentrations showed similar sensitivities and 
the lowest concentration of probe (100 nM) was selected for both parasites (Table 7). 
 
The final qPCR reaction mixes for both singleplex and multiplex reactions were based on the 
primer and probe optimisation (Tables 6 and 7). The mixes are presented in Table 8. 
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Table 5. Comparison of the DNA extraction kits. All samples were tested with three parallel 
qPCR reactions. The results are presented by average CT values and SD’s. ‘neg‘ indicates that 
the sample was negative. For negative samples the CT value of 45 was used for the calculations 
in the cases where some of the parallels were negative. The stool kit was tested both with (T) 
and without (NT) the InhibitEx tablets. 
  blood kit viral kit stool kit (T) stool kit (NT) 
sample 
dilution 
(log) 
CT value SD CT value SD CT value SD CT value SD 
-1 27,8 0,2 26,7 0,6 32,1 0,3 35,0 0,3 
-2 32,5 0,7 29,2 0,1 39,0 1,5 38,2 3,9 
-3 37,7 0,1 34,1 0,8 neg  neg  
-4 neg  40,2 3,0 neg  neg  
-5 neg  neg  neg  neg  
-6 neg  neg  neg  neg  
 
 
 
 
Table 6. Results of the primer concentration optimisation. All samples were tested with two 
parallel qPCR reactions. The results are presented by average CT values and SD’s. The 
primer concentration pairs that were considered the most suitable are marked in green for 
both parasites. 
  Giardia lamblia Cryptosporidium spp. 
[c] (nM) 
(Fwd/Rev) CT value SD CT value SD 
400/400 35,7 1,3 34,5 0,1 
400/700 35,1 0,1 35,0 0,4 
400/1000 34,9 0,0 35,2 0,0 
700/400 35,5 0,3 35,0 0,1 
700/700 34,9 0,1 35,3 0,7 
700/1000 35,1 0,3 34,7 0,2 
1000/400 35,6 0,6 35,0 0,1 
1000/700 35,1 0,3 34,8 0,1 
1000/1000 34,3 0,1 34,6 0,4 
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Table 7. Results of the probe concentration optimisation. All samples were tested with two 
parallel qPCR reactions. The results are presented by average CT values and SD’s. The probe 
concentrations that were considered the most suitable are marked in green for both parasites.  
  Giardia lamblia Cryptosporidium spp. 
[c] (nM) CT value SD CT value SD 
100 33,7 0,1 34,0 0,3 
150 34,3 0,9 33,9 0,7 
200 33,7 0,9 34.9 0,0 
 
 
Table 8. Final reaction mixes based on optimisation results. a) Reaction mixes for singleplex 
reactions for both parasites, b) reaction mix for multiplex reaction. ’Fwd’ stands for forward 
primer and ‘Rev’ stands for reverse primer. 
a) 
 Giardia lamblia  Cryptosporidium spp. 
reagent final [c] (nM) 1x (µ l)   final [c] (nM) 1x (µ l) 
2x master mix 1x 5   1x 5 
5 µM Fwd primer 700 1,4   400 0,8 
5 µM Rev primer 700 1,4   400 0,8 
50 µM probe 100 0,08   100 0,08 
H2O   0,12     1,32 
template   2     2 
            
total   10     10 
 
 
b) 
 multiplex 
reagent final [c] (nM) 1x (µ l) 
2x master mix 1x 5 
10 µM Fwd primer Crypto 400 0,4 
10 µM Rev primer Crypto 400 0,4 
50 µM probe Crypto 100 0,08 
10 µM Fwd primer Giardia 700 0,7 
10 µM Rev primer Giardia 700 0,7 
50 µM probe Giardia 100 0,08 
H2O   0,64 
template   2 
      
total   10 
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5.4 Testing of the optimised protocols 
 
As expected, the multiplex reaction showed slightly weaker template amplification for both 
parasites compared to the respective singleplex reactions (Table 9). The Cryptosporidium hominis 
qPCR was negative in the multiplex reaction. 
 
Table 9. Results of the multiplex qPCR testing. All samples were tested with three parallel 
qPCR reactions. The results are presented by average CT values and SD’s. In the table ‘neg‘ 
indicates that a negative result was obtained. 
  Giardia lamblia Cryptosporidium hominis 
qPCR type CT value SD CT value SD 
singleplex 20,6 0,3 35,8 0,2 
multiplex 21,7 0,1 neg  
 
 
The testing of the purified Cryptosporidium parvum and hominis DNA samples obtained from the 
CRU proved that the optimised protocols work and that the Cryptosporidium spp. qPCR detects 
both species. For C. parvum average CT value of three parallel qPCR reactions was 27,9 (SD 0,2) 
and for C. hominis 30,5 (SD 0,1), respectively. The results acquired for the epidemic 
Cryptosporidium parvum sample obtained from HUSLAB were positive for the pelleted and 
resuspended sample forms (Table 10). 
 
Table 10. Results of the testing of the epidemic Cryptosporidium parvum sample. All samples 
were tested with three parallel qPCR reactions. The results are presented by average CT 
values and SD’s. 
 resuspended pellet supernatant 
qPCR type CT value SD CT value SD 
singleplex 32,1 0,5 38,5 0,7 
multiplex 32,2 0,4 38,3 1,1 
 
 
All of the tested (n = 174) DiabImmune study samples provided negative results. The reaction 
functioned properly, however, given that positive controls showed positive, reproducible signals. 
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6. Discussion  
6.1 Evaluation of the used methods 
 
The aim of this thesis was to optimise the following methods – stool sample pretreatments, DNA 
extraction and qPCR – to detect Giardia lamblia and Cryptosporidium spp. from clinical stool 
samples using PCR-based amplification of their nucleic acids. The sensitivity of the protocol 
depends on each of these steps, which are discussed in the following sections. 
 
Stool sample pretreatments and their combinations in the previous literature were quite diverse. 
Furthermore, sample material types (stool, soil, sewage), DNA extraction methods and the qPCR 
amplification target genes differed considerably between publications. This made it difficult to 
choose the optimal methods, especially since their technical details were often poorly described. 
 
6.1.1 Stool sample pretreatments 
 
In this chapter, the different pretreatment protocols are discussed in terms of their execution and 
suitability for the aims of this thesis. 
  
Stool samples are cumbersome starting material for DNA extraction due to the impurities and PCR 
inhibitors. Furthermore, sometimes processing of uncentrifuged stool suspensions requires a lot of 
manual work because of their residues. 
 
Exactly similar pretreatment as in the optimised protocol no. 10 (a 10-minute heat shock at +98 °C 
and an overnight proteinase treatment at +56 °C) has not been used in previous publications. Those 
used in Verweij et al. (2003, 2004; Giardia lamblia and Cryptosporidium) and Minarovicova et al. 
(2009; Cryptosporidium) had most similarities with the method optimised in this thesis: The only 
difference was in the incubation time of the proteinase treatment. In some publications 
(Minarovicova et al., 2009) the proteinase K activity was removed with incubation of 
approximately 15 minutes in +95 °C. However, this step was not done to avoid an additional step to 
the protocol. Furthermore, the proteinase K activity does not interfere with any of the downstream 
applications used in this thesis. In addition, such step is anyway included in the qPCR protocol. 
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Variable freeze-thaw cycles are widely used in the literature. It was hypothesised based on Yu et al. 
(2009) that three freeze-thaw cycles would be enough to release the maximal amount of DNA from 
the (oo)cysts. In this thesis one, three and ten freezing-thawing cycles were tested. Surprisingly, the 
results showed that the number of cycles did not have any effect on the outcome; for Giardia 
lamblia sample the CT values were equal for all the protocols that included freeze-thaw cycles 
(Table 4, protocols 5-7 and 11-13). Effect was neither observed for the Cryptosporidium hominis 
sample. In addition to having minimal effect on the outcome, the technical execution of freeze-thaw 
cycles is laborious and hard to apply in a high-throughput format. Overall, due to the lack of exact 
descriptions of the protocols used in previous publications, the assessment of the treatment 
effectivity is difficult.  
 
In this thesis, the most sensitive method for Cryptosporidium hominis was protocol 1 which 
includes both pellet resuspension and sedimentation as concentration methods (Table 4). This 
means that the sample was first centrifuged and the pellet resuspended and the acquired sample was 
furthermore sedimentated. Thus, one explanation for the low positivity rate in the detection of this 
parasite could be very low concentration of the parasites in tested sample (it could only be detected 
after efficient concentration of oocysts). This could also explain why protocol 3 (in which 
sedimentation but no pellet resuspension was included) showed the second best results for the 
Giardia lamblia sample, but with the Cryptosporidium sample this protocol provided negative 
results (Table 4). The chosen protocol (no. 10) does not include a separate concentration step, since 
it was considered important to develop a protocol that is applicable for both of the parasites. This is 
mainly due to the multiplex aspect of the qPCR detection, but it also enables the use of the high-
throughput method. This requires compromises and the choice was based on the results of the 
optimisation carried out with the Giardia lamblia sample. The chosen protocol was eventually one 
of the two (in addition to protocol 1) that were the most sensitive for the Cryptosporidium hominis 
sample (Table 4). 
 
However, in some publications describing multiplex reactions the different parasites were treated 
differently. For example in Haque et al. (2007), the Giardia lamblia-positive samples were washed 
with PBS, pelleted and treated with six free-thaw cycles, whereas the Cryptosporidium-positive 
samples were treated with the PBS-ether-Percoll –method and sonicated five times. This publication 
also included the parasite Entamoeba histolytica, the samples of which were treated the same way 
as the Giardia lamblia samples. Yet, no explanation was provided for the use of different 
treatments. 
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Unexpectedly, Giardia lamblia samples without any pretreatments (Table 5) showed similar 
sensitivities as the second best optimised pretreatment protocols (Table 4). Furthermore, these 
samples were dilutions (starting from 10-1 dilution), so in reality these samples showed significantly 
stronger amplification than any of the pretreated ones. There was approximately an eight-month 
period between these and the subsequent tests, and for some reason, only negative CT values were 
obtained for the same samples without pretreating at the later phase. One plausible explanation is 
that the samples were formalin-fixed, which could have destroyed some of the parasite DNA in the 
sample during that period (this is discussed further in chapter 6.1.3 qPCR).  
 
6.1.2 DNA extraction 
 
This chapter includes discussion about the suitability of different extraction kits for extracting 
parasite DNA. 
 
The results from the evaluation of different extraction kits were surprising. One could assume that 
the stool kit which has been specifically designed for the extracting e.g. parasite DNA from stool 
samples would be the best option. However, both viral kit and blood kit were evidently more 
sensitive, the viral kit being the best of all (Table 5). Accordingly, Adamska et al. (2011) showed 
the blood kit to be more sensitive than the stool kit in detection of Cryptosporidium parvum. They 
used the QIAamp DNA Tissue Mini Kit (Qiagen, Hilden, Germany), but its extraction protocol is 
identical to that of the blood kit and thus comparable to the results of this thesis. The viral kit was 
originally included in the testing as it is routinely used by professor Hyöty’s laboratory in a 96-well 
format and also because it has been used by professor Vesikari’s laboratory for DNA extraction 
(Marjo Salminen, personal communications). No publication was found to have used the viral kit 
for this purpose, but according to the manufacturer’s instructions, the viral kit extracts both DNA 
and RNA. 
 
The stool kit was tested using the InhibitEx tablet that forms a matrix which absorbs the impurities 
and PCR inhibitors possibly present in the stool sample. The results obtained with the tablet were 
slightly better than without it (Table 5). Regardless, using the InhibitEx tablet in a 96-well format 
would be very laborious and in fact not feasible: the tablet is rather large and thus requires a 2 ml 
tube at the smallest. 
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6.1.3 qPCR 
 
In this chapter, the reliability and usability of the qPCR reaction and different features affecting its 
results are discussed. 
 
The optimisation increased the sensitivity of the qPCR reaction, especially with the Giardia lamblia 
sample. The best method was 10 000 times more sensitive than the least sensitive method (Table 4). 
This also applies to the Cryptosporidium hominis sample for which the best protocol (no. 1) showed 
approximately 100 times stronger template amplification than the weakest ones (Table 4). 
 
The optimisation was difficult for Cryptosporidium hominis sample because of the low positivity 
(i.e. quite high CT values were obtained throughout the process). However, the CRU had obtained 
CT values of approximately 28 from the same samples (Kristin Elwin, personal communications), 
which equates to approximately 100 times higher sensitivity than the optimised method of this 
thesis. This comparison could be misleading as the CRU had used floating oocyst concentration 
method for purification and the remaining execution details (such as other possible pretreatments, 
DNA extraction methods or the template volume in the qPCR reaction) are not known. 
 
Another possible explanation for the significant difference in the CT values obtained from the same 
samples by the CRU is that we used formalin-fixed stool samples and they used fresh stool samples. 
In this case, formalin refers to 10 % neutral buffered formaldehyde. Formalin is traditionally used 
as a fixative to ensure preservation of the stool samples and to facilitate transportation (Paglia and 
Visca, 2004). However, it is generally known that fixation with formalin has many downsides. 
Formalin e.g. reduces DNA solubility and promotes its fragmentation by hydrolysis of the 
phosphodiester bonds (Paglia and Visca, 2004; Srinivasan et al., 2002). These changes hamper 
DNA extraction and qPCR detection. Formalin can also create apyrimidinic or apurinic sites on the 
DNA or produce cytosine cross-links. These modifications interfere with Taq DNA polymerase and 
therefore the reaction can decelerate and become less efficient (Srinivasan et al., 2002). Another 
consequence is that the DNA polymerase can create mutations at such sites during the 
amplification. However, here qualification of the qPCR amplification products is not critical due to 
the use of specific probes. Hence, only extensive mutations to the primer or probe binding sites 
could affect the results, and these are highly improbable to occur. On the other hand, Paglia and 
Visca (2004) claim that formalin fixation can also be advantageous: Formalin might prevent the  
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qPCR inhibition caused by the other impurities and inhibitors present in the sample. 
 
The optimised Cryptosporidium spp. qPCR method was tested using ready-extracted DNA obtained 
from the CRU. The results showed high amounts of template with small SD’s and the qPCR 
reaction was thus confirmed to detect the Cryptosporidium spp. Furthermore, the tested epidemic 
sample proved that the complete optimised protocol (with an additional concentration step) works, 
because relatively strong template amplification was obtained (Table 10). This indicates that with 
suspected Cryptosporidium spp.-positive samples a concentration step, such as pellet resuspension, 
should be added to the protocol. 
 
The qPCR reaction volumes were significantly lower than the recommendations in the qPCR kit. 
This could pose a problem when small sample amounts are tested since pipetting of small volumes 
accurately is difficult and SD’s become substantial. Here however, large sample amounts were 
tested simultaneously and adequate volumes of reagents could be used in the preparation of the 
reaction master mix to ensure accuracy. 
 
One could argue the comparability and reproducibility of qPCR method. The standard deviation 
was high for samples with the CT values greater than 36 cycles (Tables 4 and 5). This observation is 
coherent with the literature (ten Hove et al., 2007). In such cases the sample is likely to contain only 
few copies of the target DNA and it is coincidental whether or not the primers bind to their target 
DNA sequences. This results in high SD’s and the sample might appear either positive or negative 
randomly. This seemed to be the case with the Cryptosporidium hominis sample for which the 
template amplification was constantly quite weak. In the cases where the CT values were smaller 
than approximately 36 cycles, the SD’s were small, and method can thus be considered very 
reproducible. 
 
Testing of the multiplex qPCR reaction showed, as expected, that singleplex reactions had slightly 
stronger template amplification than the multiplex reactions (for Giardia lamblia sample; Table 9). 
The differences were however minimal, and probably insignificant, which could be explained by 
the very strong template amplification in the sample. For Cryptosporidium hominis sample a 
negative result was obtained in the multiplex reaction (Table 9). This was understandable, though, 
because the CT values obtained for the sample in the singleplex reaction were close to the detection 
limit. 
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All tested DiabImmune samples were negative. This is not unexpected per se, since samples were 
randomly collected from young children representing background population and these children had 
no symptoms of acute parasite infection. In addition, relatively low number of samples (n = 174) 
was tested. Normally these parasites occur in epidemics and during non-epidemic periods they are 
rare in Finland and Estonia. The positive sample used to test the optimised protocol was collected 
during an epidemic in southern Finland in the fall 2012. The qPCR results showed that this sample 
contained high amounts of Cryptosporidium parvum and parallel qPCR tests had small SD (Table 
10). The entire optimised protocol was thus proven to detect the specific parasites and the qPCR 
reaction was confirmed to detect Cryptosporidium parvum too.  
 
6.2 Future perspectives 
 
Diagnostic laboratories will probably continue applying microscopic and antigen detection-based 
techniques, whereas qPCR remains more likely to be used in research laboratories. However, the 
protocol optimised here clearly offers a high-throughput, sensitive and multiplex option for the 
detection of Giardia lamblia and Cryptosporidium spp. from human stool samples. Most of the 
methods presented in the previous literature are time-consuming and laborious, containing multiple 
pretreatment steps that require extensive laboratory equipment. These methods are thus very hard to 
apply in a high-throughput format. The method optimised in this thesis requires only a qPCR 
machine as special laboratory equipment and is applicable for the processing of large number of 
samples and detection of multiple parasites simultaneously. Moreover, the method is less expensive 
for the aforementioned reasons. Thus, it could be applied also by diagnostic laboratories which have 
experience from PCR-based microbial diagnostics. Professor Hyöty’s laboratory will use the 
protocol in their research, for example in the DiabImmune study. 
 
More detectable parasites or other microorganisms can be added to the multiplex qPCR, however 
TaqMan-based systems can be run with four at most (Hlousek et al., 2012). There are two reasons 
for this (Hlousek et al., 2012). Firstly, if more than four reactions are included in the multiplex 
reaction, part of the excitation or emission spectra of the probes fluorescent dyes’ are likely to 
overlap and impair accurate detection by the software. Secondly, multiplex interference could 
significantly hamper the reactions. Undoubtedly, also the chosen pretreatments limit the possible 
other microorganisms that could be added to the same qPCR reaction with Giardia lamblia and 
Cryptosporidium spp. The environment created in the sample with a heat shock and a proteinase 
treatment is quite harsh, and for example most viruses and their nucleic acids could not endure it. 
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Some enteroviruses have been tested from the same DiabImmune samples which were tested in this 
thesis for the presence of parasites. In fact, the samples which had been positive in enterovirus PCR 
in previous analyses without sample pretreatments turned negative when exposed to the present 
pretreatment protocol. This is natural since the RNA genome of enteroviruses is easily destroyed by 
heat-treatment. 
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7. Conclusions 
 
The purpose of this study was to optimise PCR-based detection methods for Giardia lamblia and 
Cryptosporidium spp. and to test them with clinical samples collected for the DiabImmune study. It 
was essential to develop protocol in a high-throughput format. The optimisation resulted in a 
pretreatment protocol that was a combination of methods described in the literature (a heat shock 
and a proteinase treatment) but not identical to any of the references applied. Several other 
combinations were also tested, but their performance was clearly less optimal and some of the 
pretreatments (e.g. freeze-thaw cycles) were also quite laborious. Optimisation was quite difficult 
for the Cryptosporidium hominis sample; Hence, the optimal protocol is mostly based on the tests 
carried out with the Giardia lamblia sample. 
 
Three different kits were tested for DNA extraction. Surprisingly, the kit designed for extraction of 
viral RNA was considered the best, though the kit has not been described in the literature for 
extraction of parasite DNA. A ready-made 96-well format was available with this kit, thus it was 
not necessary to generate it separately. The qPCR reactions were optimised for primer and probe 
concentrations and for both singleplex and multiplex reactions. Even though the optimisation was 
carried out with Cryptosporidium hominis, the protocol was tested also with a Cryptosporidium 
parvum sample. 
 
The developed protocol is relatively fast, inexpensive and can be applied in a high-throughput 
format. The method enables processing of large sample amounts and detection of two 
epidemiologically important intestinal parasites. In addition, the method could be further developed 
to detect other microorganisms. 
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Appendix 1  
Table S1. Hank’s buffer solution.  
  
NaCl 16 g 
KCl 0,8 g 
Na2HPO4 x 2 H2O 0,12 g 
KH2PO4 0,12 g 
MgSO4 x 7 H2O 0,2 g 
glucose 2,0 g 
phenol red 0,02 g 
CaCl2 (anhydr.) 0,28 g 
MgCl x 6 H2O 0,2 g 
H2O 2000 ml   
 
 
adjusted to pH = 7,0 with 7,5 % NaHCO3. 
